Previous 10 | Next 10 |
home / stock / chexf / chexf news
PHOENIX, May 13, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed Avivagen Inc. (CHEXF) , a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, pro...
Avivagen ( OTCPK:CHEXF ) has begun to explore the combination of its OxC-beta product with licensed cannabis products. More news on: Avivagen Inc., Healthcare stocks news, Read more ...
OTTAWA, March 06, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”) reported today its unaudited financial results for Q1 2019. For the three-month period ended January 31, 2019, the Corporation reported revenues of $322,125 &...
OTTAWA, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce that its partner in the Philippines, UNAHCO, has purchased 2 metric tons of OxC-beta™ Livestock, and follows an order of 2 metric tons delivered to UNAHCO in November ...
OTTAWA, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce that it has signed a partnership with CSA Animal Nutrition providing for the sales and distribution of OxC-beta™ Livestock (“OxC-beta”) by CSA in the Uni...
OTTAWA, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) reported its audited financial results for the year ended October 31, 2018. Unless otherwise noted, all figures are in Canadian currency. The Corporation’s audited year end Financial Stat...
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. OTTAWA, Jan. 18, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Company...
OTTAWA, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce its 2019 letter to shareholders by Chairman and interim CEO Kym Anthony. To our shareholders: As the consumer, scientific and regulatory climates continue to support the...
OTTAWA, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) announces the appointment of UHY McGovern Hurley LLP as auditors. UHY McGovern Hurley LLP has been appointed to carry out the audit of Avivagen’s financial statements for the year ende...
OTTAWA, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or “Corporation”), a world leader in natural alternatives to antibiotics with its OxC-beta™ technology, today announced that it will be requesting approval from the TSX Venture ...
News, Short Squeeze, Breakout and More Instantly...
Phoenix, Arizona--(Newsfile Corp. - October 2, 2019) - The Stock Day Podcast welcomed Avivagen Inc. (CHEXF) ("the Company"), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune f...
PHOENIX, May 13, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed Avivagen Inc. (CHEXF) , a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, pro...
OTTAWA, March 06, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”) reported today its unaudited financial results for Q1 2019. For the three-month period ended January 31, 2019, the Corporation reported revenues of $322,125 &...